Fosfomycin Tops Fluoroquinolones for Prostate Biopsy Prophylaxis
In a meta-analysis, the risk of infectious complications was 78% lower with fosfomycin trometamol versus fluoroquinolones in men undergoing TRUS-guided prostate biopsy.
Diagnosis & Disease Information
Routine Office Urine Culture Before Prostate Biopsy Is Unnecessary
In a single center study, asymptomatic bacteriuria resolved before prostate biopsy, without additional treatment.
Is It Safe to Avoid Biopsy in Men With Elevated PSA?
Multiparametric magnetic resonance imaging in conjunction with transrectal ultrasound-guided biopsy improves discrimination between clinically significant and insignificant prostate tumors and can spare patients unnecessary biopsies.
Repeat Prostate Biopsies Do Not Raise Risk of Post-RP Complications
Rates of erectile dysfunction and urinary incontinence at 1, 2, and 3 years after radical surgery are not higher among men who have multiple prostate biopsies while on active surveillance for prostate cancer.
Structured Investigation of Outpatient Transperineal Prostate Biopsy
The transperineal approach to prostate biopsy has recently been adopted at many centers as an alternative to TRUS-B.
Less Frequent Biopsies May Be Appropriate for PCa Active Surveillance
Investigators who compared 4 active surveillance cohorts found that biennial prostate biopsies appear to be an acceptable alternative to annual biopsies.
Top Complaint After Prostate Biopsy Is Infection
Most common infection in prostate biopsy was E. coli, followed by mild bleeding.
Combined Urinary Testing Helps Detect Aggressive PCa, Avoid Biopsy
Combining testing of urinary T2:ERG, PCA3 at thresholds that detected aggressive prostate cancer improved specificity from 18% to 39%.
Biopsy Timing in Active Surveillance Not Tied to PCa Reclassification
But PSA density and body mass index are associated with prostate cancer reclassification.
Prostate Biopsy May Be Avoidable if MRI Findings Are Negative
In a study, systematic biopsy detected clinically significant prostate cancer in only 3% of men with negative findings on multiparametic MRI.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...